Annual FCF
$183.15 M
-$90.47 M-33.06%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual free cash flow is $183.15 million, with the most recent change of -$90.47 million (-33.06%) on December 31, 2023.
- During the last 3 years, IRWD annual FCF has risen by +$16.16 million (+9.68%).
- IRWD annual FCF is now -33.06% below its all-time high of $273.63 million, reached on December 31, 2022.
Performance
IRWD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$9.87 M
-$23.54 M-70.46%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly free cash flow is $9.87 million, with the most recent change of -$23.54 million (-70.46%) on September 30, 2024.
- Over the past year, IRWD quarterly FCF has stayed the same.
- IRWD quarterly FCF is now -87.69% below its all-time high of $80.16 million, reached on March 31, 2023.
Performance
IRWD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$123.82 M
-$22.54 M-15.40%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM free cash flow is $123.82 million, with the most recent change of -$22.54 million (-15.40%) on September 30, 2024.
- Over the past year, IRWD TTM FCF has stayed the same.
- IRWD TTM FCF is now -57.26% below its all-time high of $289.67 million, reached on March 31, 2023.
Performance
IRWD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IRWD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.1% | 0.0% | 0.0% |
| 3 y3 years | +9.7% | -84.7% | -52.7% |
| 5 y5 years | +357.1% | -84.7% | -52.7% |
IRWD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.1% | at low | -87.7% | at low | -57.3% | at low |
| 5 y | 5-year | -33.1% | +5079.7% | -87.7% | at low | -57.3% | +3401.6% |
| alltime | all time | -33.1% | +164.7% | -87.7% | +109.2% | -57.3% | +143.8% |
Ironwood Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.87 M(-70.5%) | $123.82 M(-15.4%) |
| Jun 2024 | - | $33.41 M(-25.6%) | $146.36 M(-1.1%) |
| Mar 2024 | - | $44.92 M(+26.1%) | $147.91 M(-19.2%) |
| Dec 2023 | $183.15 M(-33.1%) | $35.62 M(+9.9%) | $183.15 M(-19.2%) |
| Sep 2023 | - | $32.41 M(-7.3%) | $226.74 M(-13.9%) |
| Jun 2023 | - | $34.96 M(-56.4%) | $263.36 M(-9.1%) |
| Mar 2023 | - | $80.16 M(+1.2%) | $289.67 M(+5.9%) |
| Dec 2022 | $273.63 M(+4.6%) | $79.21 M(+14.8%) | $273.63 M(+5.7%) |
| Sep 2022 | - | $69.03 M(+12.6%) | $258.86 M(-2.2%) |
| Jun 2022 | - | $61.28 M(-4.4%) | $264.76 M(+5.0%) |
| Mar 2022 | - | $64.11 M(-0.5%) | $252.05 M(-3.7%) |
| Dec 2021 | $261.63 M(+56.7%) | $64.44 M(-14.0%) | $261.63 M(+5.2%) |
| Sep 2021 | - | $74.93 M(+54.3%) | $248.68 M(+9.4%) |
| Jun 2021 | - | $48.57 M(-34.1%) | $227.38 M(+14.5%) |
| Mar 2021 | - | $73.69 M(+43.1%) | $198.52 M(+18.9%) |
| Dec 2020 | $166.99 M(+4622.7%) | $51.48 M(-4.0%) | $166.99 M(+18.9%) |
| Sep 2020 | - | $53.63 M(+172.1%) | $140.42 M(+18.5%) |
| Jun 2020 | - | $19.71 M(-53.3%) | $118.48 M(+34.5%) |
| Mar 2020 | - | $42.16 M(+69.3%) | $88.09 M(+2391.1%) |
| Dec 2019 | $3.54 M(-105.0%) | $24.91 M(-21.4%) | $3.54 M(-128.6%) |
| Sep 2019 | - | $31.69 M(-396.7%) | -$12.36 M(-82.2%) |
| Jun 2019 | - | -$10.68 M(-74.8%) | -$69.28 M(-14.7%) |
| Mar 2019 | - | -$42.38 M(-570.0%) | -$81.22 M(+14.0%) |
| Dec 2018 | -$71.23 M(-31.2%) | $9.02 M(-135.7%) | -$71.23 M(-20.0%) |
| Sep 2018 | - | -$25.23 M(+11.5%) | -$89.06 M(-7.7%) |
| Jun 2018 | - | -$22.63 M(-30.1%) | -$96.54 M(-9.8%) |
| Mar 2018 | - | -$32.40 M(+267.8%) | -$107.07 M(+3.4%) |
| Dec 2017 | -$103.56 M(-20.4%) | -$8.81 M(-73.1%) | -$103.56 M(-10.1%) |
| Sep 2017 | - | -$32.70 M(-1.4%) | -$115.13 M(+36.3%) |
| Jun 2017 | - | -$33.16 M(+14.8%) | -$84.46 M(-46.6%) |
| Mar 2017 | - | -$28.88 M(+41.7%) | -$158.18 M(+21.5%) |
| Dec 2016 | -$130.14 M | -$20.39 M(+904.2%) | -$130.14 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$2.03 M(-98.1%) | -$129.91 M(-15.9%) |
| Jun 2016 | - | -$106.88 M(>+9900.0%) | -$154.52 M(+108.7%) |
| Mar 2016 | - | -$847.00 K(-95.8%) | -$74.05 M(-33.3%) |
| Dec 2015 | -$110.98 M(-30.3%) | -$20.15 M(-24.4%) | -$110.98 M(-3.2%) |
| Sep 2015 | - | -$26.65 M(+0.9%) | -$114.65 M(-9.8%) |
| Jun 2015 | - | -$26.41 M(-30.1%) | -$127.16 M(-7.6%) |
| Mar 2015 | - | -$37.77 M(+58.5%) | -$137.69 M(-13.5%) |
| Dec 2014 | -$159.11 M(-43.8%) | -$23.82 M(-39.2%) | -$159.11 M(-12.1%) |
| Sep 2014 | - | -$39.16 M(+6.0%) | -$181.08 M(-9.8%) |
| Jun 2014 | - | -$36.94 M(-37.6%) | -$200.86 M(-18.4%) |
| Mar 2014 | - | -$59.19 M(+29.2%) | -$246.02 M(-13.1%) |
| Dec 2013 | -$282.95 M(+238.4%) | -$45.80 M(-22.3%) | -$282.95 M(+7.6%) |
| Sep 2013 | - | -$58.94 M(-28.2%) | -$262.99 M(+56.0%) |
| Jun 2013 | - | -$82.09 M(-14.6%) | -$168.62 M(+27.7%) |
| Mar 2013 | - | -$96.12 M(+271.9%) | -$132.03 M(+57.9%) |
| Dec 2012 | -$83.61 M(-1.5%) | -$25.84 M(-172.9%) | -$83.61 M(+21.0%) |
| Sep 2012 | - | $35.44 M(-177.9%) | -$69.12 M(-47.1%) |
| Jun 2012 | - | -$45.50 M(-4.6%) | -$130.54 M(+24.0%) |
| Mar 2012 | - | -$47.70 M(+320.3%) | -$105.24 M(+23.9%) |
| Dec 2011 | -$84.92 M(-0.2%) | -$11.35 M(-56.3%) | -$84.92 M(+11.2%) |
| Sep 2011 | - | -$25.98 M(+28.6%) | -$76.34 M(-4.1%) |
| Jun 2011 | - | -$20.21 M(-26.2%) | -$79.63 M(-6.1%) |
| Mar 2011 | - | -$27.38 M(+886.3%) | -$84.83 M(-0.3%) |
| Dec 2010 | -$85.12 M(+1121.4%) | -$2.78 M(-90.5%) | -$85.12 M(+17.2%) |
| Sep 2010 | - | -$29.26 M(+15.2%) | -$72.65 M(+45.5%) |
| Jun 2010 | - | -$25.41 M(-8.2%) | -$49.93 M(+260.4%) |
| Mar 2010 | - | -$27.68 M(-385.5%) | -$13.85 M(+98.8%) |
| Dec 2009 | -$6.97 M(-86.4%) | $9.69 M(-248.3%) | -$6.97 M(-58.2%) |
| Sep 2009 | - | -$6.54 M(-161.3%) | -$16.66 M(+64.6%) |
| Jun 2009 | - | $10.67 M(-151.3%) | -$10.12 M(-51.3%) |
| Mar 2009 | - | -$20.79 M | -$20.79 M |
| Dec 2008 | -$51.13 M(+443.3%) | - | - |
| Dec 2007 | -$9.41 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual FCF year-on-year change?
- What is Ironwood Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly FCF year-on-year change?
- What is Ironwood Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM FCF year-on-year change?
What is Ironwood Pharmaceuticals annual free cash flow?
The current annual FCF of IRWD is $183.15 M
What is the all time high annual FCF for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual free cash flow is $273.63 M
What is Ironwood Pharmaceuticals annual FCF year-on-year change?
Over the past year, IRWD annual free cash flow has changed by -$90.47 M (-33.06%)
What is Ironwood Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of IRWD is $9.87 M
What is the all time high quarterly FCF for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly free cash flow is $80.16 M
What is Ironwood Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, IRWD quarterly free cash flow has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM free cash flow?
The current TTM FCF of IRWD is $123.82 M
What is the all time high TTM FCF for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM free cash flow is $289.67 M
What is Ironwood Pharmaceuticals TTM FCF year-on-year change?
Over the past year, IRWD TTM free cash flow has changed by $0.00 (0.00%)